A phase 1b study of once-weekly KRd in patients with newly diagnosed multiple myeloma

Adding daratumumab to existing multiple myeloma regimen of lenalidomide, bortezomib and dexamethasone

D-VTd in transplant-eligible newly diagnosed MM: Subgroup analysis of high-risk patients in CASSIOPEIA

Real-world use of carfilzomib therapy among patients with existing cardiovascular medical history

Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma

Twice-weekly vs once-weekly Krd in early relapsed refractory multiple myeloma

HORIZON: Melflufen in high risk relapsed refractory multiple myeloma patients with extramedullary disease

Improved outcomes from quadruplet KCRD induction in newly diagnosed myeloma patients

Once-weekly carfilzomib combined with lenalidomide and dexamethasone for multiple myeloma

What is the role of autologous stem cell transplant in multiple myeloma?

First results of the GMMG-CONCEPT trial for multiple myeloma

Iberdomide in combination with dexamethasone for multiple myeloma